AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients.
The Company’s focus is on some of the most challenging cancers. It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyse changes in the practice of medicine and transform the patient experience. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.
Astellas is a global pharmaceutical company, working at the forefront of healthcare change to turn innovative science into value for patients. Making a positive impact on patients’ lives is the purpose behind everything we do. We are relentless in our pursuit of scientific progress and in tackling unmet medical needs. We work every day to leverage what sets us apart - our focus on patients, our pioneering spirit, our culture of innovation, and the passion of our talented people to pursue the best solutions for patients.
BeiGene is a global biotechnology company that is discovering and developing innovative oncology treatments that are more accessible and affordable to cancer patients worldwide.
The company has a commercial presence in more than 65 markets, with products treating various forms of cancer. BeiGene’s broad and deep pipeline of novel therapeutics, which it is advancing with its internal capabilities and through partnerships, has the potential to address 80 percent of the world’s cancers by incidence.
BeiGene is committed to radically improving access to medicines for patients who need them.
To learn more about BeiGene, please visit https://www.beigene.com.au/
Integrated Sciences, established in 1983, specialises in the sale and support of Clinical Diagnostics, Molecular Diagnostics, Point of Care and Research products in Australia and New Zealand.
We have partnered with Mission Bio a life sciences company that accelerates discoveries and cures by equipping researchers with the tools they need to improve how we measure and predict resistance and response to precision therapies.
Mission Bio’s multi-omics approach helps connect genotype to phenotype at the single-cell level and gain comprehensive insights into disease progression, development of resistance and minimal residual disease (MRD).
The South Australian Genomics Centre (SAGC) was established in July 2020 as a State-wide genomics facility to support best-in-class research in SA, as well as nationally and internationally.
The SAGC provides a broad range of genomics and bioinformatics services including advanced technologies, such as single cell and spatial transcriptomics. The SAGC is pleased to support researchers and clinicians from all our partners institutes as well as industry partners and other external clients. All areas of genomics including animal, plant, environmental, microbial, and human genomics are supported.
The SAGC is proudly supported by NCRIS / BioPlatforms, and our partners (SAHMRI, University of South Australia, Flinders University, The University of Adelaide, the AGRF, and AWRI.
Contact Us for a project consultation and follow us on X and LinkedIN to see and hear the latest.
STEMCELL Technologies provides high-quality cell culture media, cell separation technologies, instruments, accessory products, and educational resources to scientists around the world working on stem cell, immunology, cancer, regenerative medicine, and cellular therapy research.
At STEMCELL, we are dedicated to improving lives through advanced knowledge and scientific discovery, through our commitment to fostering diversity and inclusion in STEM and the life sciences industry, and through our investments in sustainability, community, and social responsibility.
Rooted in scientific expertise and rigor, we are a company of Scientists Helping Scientists, and we care deeply about making the world a better place.
VectorBuilder: Revolutionize Gene Delivery from Research to Therapy
VectorBuilder is specialising in advanced genetic engineering solutions for research and medicine.
As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.
We offer a range of products and services including vector design and cloning, virus packaging (Lentivirus, Adenovirus, AAV, MMLV, MSCV, Baculovirus, VSV and HSV), library construction, stable cell line generation, IVT mRNA synthesis and GMP manufacturing of clinical-grade plasmids, mRNAs and viruses.
For more information visit www.pfizer.com.au
WEHI is where the world’s brightest minds collaborate and innovate to make life-changing scientific discoveries that help people live healthier for longer. Our medical researchers have been serving the community for more than 100 years, making transformative discoveries in cancers, infectious and immune diseases, developmental disorders and healthy ageing.
WEHI brings together diverse and creative people with different experience and expertise to solve some of the world’s most complex health problems. With partners across science, health, government, industry and philanthropy, we are committed to long-term discovery, collaboration and translation. At WEHI, we are brighter together.
Find out more at www.wehi.edu.au
Join the mailing list to be kept up to date with information on the New Directions in Leukaemia Research 2024 Meeting. Join mailing list here.
Event Studio Group
For all conference enquiries, please talk to the team at Event Studio Group Pty Ltd:
E: NDLR2024@eventstudio.com.au | P: +61 (08) 8379 8222
To view the privacy statement, click here